Week of July 25, 2023 | Vol. 12, Issue 29

Linkedin  

In This Issue

Upcoming Events

Industry M&A Activity

Recent Transactions

Trading Comps

Market Reports

M&A Pipeline

Featured Headlines

Tanner Updates



Quick Links

Who We Are

Investment Banking

Strategic Capital

Research


Contact Information

Xan Smith

Managing Director

Business Development

xsmith@bourne-partners.com


Jeremy C. Johnson

Senior Managing Director, Head of Investment Banking

jjohnson@bourne-partners.com

Industry Snapshot

Above is an overview of recent industry M&A activity. Click on the chart to view complete transaction tables broken out by industry sub sectors. For additional information, see the Industry M&A Activity section below.

UPCOMING EVENTS

Events Hosted or Attended by Bourne Partners

595330 image
1686840562811 image

NACDS TSE

August 12-14, 2023 - San Diego, CA

Contract Pharma 2023

September 5-8, 2023 - New Brunswick, NJ

Bourne Partners Annual CEO Summit 2023

Invitation Only

October 4, 2023 - Charlotte, NC

CPHI Barcelona

October 24-26, 2023 - Barcelona, Spain

Supply Side West 2023

October 23-27, 2023 - Las Vegas, NV

INDUSTRY M&A ACTIVITY

Recent Transactions, Trading Comps, Market Reports, M&A Pipeline

Recent Transactions

An Overview of Transactions Within Market Sub-segments

Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.

M&A Transactions

Pharma & Biotech

12 transactions totaling $4.2 billion


Supplies, Equipment & Services

16 transactions totaling $601 million


Healthcare Facilities & Distributors

6 transactions totaling $35 million


Healthcare IT & Managed Care

7 transactions totaling $1.4 billion

Private Placements

Pharma & Biotech

19 transactions totaling $810 million


Supplies, Equipment & Services

11 transactions totaling $644 million


Healthcare Facilities & Distributors

1 transaction


Healthcare IT & Managed Care

8 transactions totaling $154 million

Public Offerings

Pharma & Biotech

22 transactions totaling $1.5 billion


Supplies, Equipment & Services

6 transactions


Healthcare Facilities & Distributors

2 transactions totaling $28 million


Healthcare IT & Managed Care

0 transactions

Trading Comps

A Breakdown of Relevant Trading Multiples

This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.

Market Reports

Insight Into Healthcare Related Industries

Pharma Services Sector Snapshot 1H 2022

August 2022

Pharma Sector Snapshot 1H 2022

August 2022

Market Insight Capital Markets Update

October 2022

M&A Pipeline

Representative Current Retained Sell-Side and Partnering Opportunities

Project Beach

Pharma Services | Sell-Side

Acquisition opportunity of Clinical Trial Services Provider


Project Elevate

Pharma Services | Capital Raise

Investment opportunity in Digital Health patient adherence platform


Project Ester

Consumer Health | Strategic Partnering 

Partnering opportunity for launch and commercialization of novel OTC dry eye product


Project Harold

Pharma Services | Sell-Side

Acquisition opportunity of U.S. based Sterile CDMO

Project Panther

Pharma Services | Sell-Side

Acquisition opportunity of OTC and personal care CDMO


Project Pine

Pharma Services | Capital Raise

Investment opportunity in sterile injectable Pharmaceutical Manufacturer 


Project Trident

Pharma | Buy-Side

Seeking generic liquids or established brands across all formats sold through the hospital / institutional channel

Featured Headlines

A Sampling of Industry Headlines

Signant Health snaps up DSG to expand decentralized trial offerings

Fierce Biotech - Jul 19, 2023

Kindeva Drug Delivery, Chiesi Group, and H&T Presspart Team Up

Contract Pharma - Jul 19, 2023

Surge in Heart Procedures Helps Drive Johnson & Johnson Revenue

WSJ - Jul 19, 2023

Pfizer plant in North Carolina damaged by tornado

Reuters - Jul 19, 2023

NAMSA buys German CRO Clinical Research Institute for undisclosed price

Fierce Biotech - Jul 19, 2023

Elliott Takes Big Stake in Drugmaker Catalent

WSJ - Jul 19, 2023

ABL Enters Seven-year Multimillion Dollar Contract with NIH

Contract Pharma - Jul 20, 2023

TANNER NEWS

Linkedin  
Rare-Rev-inar-Graphics-3-1024x535 image

Insights From a Multi-Stakeholder Discussion on Early Access Pathways to Medicine


In partnership with RARE Revolution, Tanner Pharma Group co-hosted a webinar that brought together stakeholders to discuss early access pathways to medicines. Discussion topics covered the role of patient groups and healthcare professionals, communication strategies, real-world data collection, equitable access, ethical issues and patient pathways to access. Read more.